{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T19:37:01Z","timestamp":1712086621340},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,12]]},"DOI":"10.7759\/cureus.32447","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T20:30:11Z","timestamp":1670877011000},"source":"Crossref","is-referenced-by-count":2,"title":["A Case of Choledocholithiasis and Obstructive Jaundice With a Very High Serum Carbohydrate Antigen 19-9 (CA 19-9) Level: A Case Report and Review of Literature"],"prefix":"10.7759","author":[{"given":"Muhammad","family":"Ghallab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazem","family":"Abosheaishaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishank","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salma","family":"Abdelmoteleb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Stern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01542654","article-title":"Colorectal carcinoma antigens detected by hybridoma antibodies","volume":"5","author":"Koprowski H","year":"1979","unstructured":"Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer P. Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet. 1979, 5:957-71. 10.1007\/BF01542654","journal-title":"Somatic Cell Genet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4240\/wjgs.v12.i12.468","article-title":"Carbohydrate antigen 19-9 - tumor marker: past, present, and future","volume":"12","author":"Lee T","year":"2020","unstructured":"Lee T, Teng TZJ, Shelat VG. Carbohydrate antigen 19-9 - tumor marker: past, present, and future. World J Gastrointest Surg. 2020, 12:468-90. 10.4240\/wjgs.v12.i12.468","journal-title":"World J Gastrointest Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2007.06.312","article-title":"How useful are clinical, biochemical, and cross-sectional imaging features in predicting potentially malignant or malignant cystic lesions of the pancreas? Results from a single institution experience with 220 surgically treated patients","volume":"206","author":"Goh BK","year":"2008","unstructured":"Goh BK, Tan YM, Thng CH, et al.. How useful are clinical, biochemical, and cross-sectional imaging features in predicting potentially malignant or malignant cystic lesions of the pancreas? Results from a single institution experience with 220 surgically treated patients. J Am Coll Surg. 2008, 206:17-27. 10.1016\/j.jamcollsurg.2007.06.312","journal-title":"J Am Coll Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.02.031","article-title":"Urinary and serum carbohydrate antigen 19-9 as a biomarker in ureteropelvic junction obstruction in children","volume":"183","author":"Kajbafzadeh AM","year":"2010","unstructured":"Kajbafzadeh AM, Elmi A, Talab SS, Emami H, Esfahani SA, Saeedi P. Urinary and serum carbohydrate antigen 19-9 as a biomarker in ureteropelvic junction obstruction in children. J Urol. 2010, 183:2353-60. 10.1016\/j.juro.2010.02.031","journal-title":"J Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65720-8","article-title":"Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases","volume":"10","author":"Kim S","year":"2020","unstructured":"Kim S, Park BK, Seo JH, et al.. Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases. Sci Rep. 2020, 10:8820. 10.1038\/s41598-020-65720-8","journal-title":"Sci Rep"},{"key":"ref6","article-title":"CA19-9 has no value as a tumor marker in obstructive jaundice [Article in German]","volume":"129","author":"Peterli R","year":"1999","unstructured":"Peterli R, Meyer-Wyss B, Herzog U, Tondelli P. CA19-9 has no value as a tumor marker in obstructive jaundice [Article in German]. Schweiz Med Wochenschr. 1999, 129:77-9.","journal-title":"Schweiz Med Wochenschr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01234.x","article-title":"A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve","volume":"94","author":"Kim HJ","year":"1999","unstructured":"Kim HJ, Kim MH, Myung SJ, et al.. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve. Am J Gastroenterol. 1999, 94:1941-6. 10.1111\/j.1572-0241.1999.01234.x","journal-title":"Am J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0953-6205(02)00002-x","article-title":"High CA 19-9 levels in benign biliary tract diseases","volume":"13","author":"Katsanos KH","year":"2002","unstructured":"Katsanos KH, Kitsanou M, Christodoulou DK, Tsianos EV. High CA 19-9 levels in benign biliary tract diseases. Eur J Intern Med. 2002, 13:132-5. 10.1016\/s0953-6205(02)00002-x","journal-title":"Eur J Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/00015458.2004.11679571","article-title":"Gall-bladder agenesis presenting with obstructive jaundice and elevated CA 19-9","volume":"104","author":"Trompetas V","year":"2004","unstructured":"Trompetas V, Panagopoulos E, Ramantanis G. Gall-bladder agenesis presenting with obstructive jaundice and elevated CA 19-9. Acta Chir Belg. 2004, 104:347-9. 10.1080\/00015458.2004.11679571","journal-title":"Acta Chir Belg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/01.smj.0000198465.21994.19","article-title":"Elevated CA 19-9 levels in a patient with Mirizzi syndrome: case report","volume":"99","author":"Sanchez M","year":"2006","unstructured":"Sanchez M, Gomes H, Marcus EN. Elevated CA 19-9 levels in a patient with Mirizzi syndrome: case report. South Med J. 2006, 99:160-3. 10.1097\/01.smj.0000198465.21994.19","journal-title":"South Med J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4076\/1757-1626-2-6662","article-title":"Highly elevated serum levels of CA 19-9 in choledocholithiasis: a case report","volume":"2","author":"Marcouizos G","year":"2009","unstructured":"Marcouizos G, Ignatiadou E, Papanikolaou GE, Ziogas D, Fatouros M. Highly elevated serum levels of CA 19-9 in choledocholithiasis: a case report. Cases J. 2009, 2:6662. 10.4076\/1757-1626-2-6662","journal-title":"Cases J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4318\/tjg.2010.0139","article-title":"Extraordinarily elevated serum levels of CA 19-9 and rapid decrease after successful therapy: a case report and review of literature","volume":"21","author":"Korkmaz M","year":"2010","unstructured":"Korkmaz M, \u00dcnal H, Sel\u00e7uk H, Yilmaz U. Extraordinarily elevated serum levels of CA 19-9 and rapid decrease after successful therapy: a case report and review of literature. Turk J Gastroenterol. 2010, 21:461-3. 10.4318\/tjg.2010.0139","journal-title":"Turk J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastrohep.2016.02.008","article-title":"Significantly elevated CA 19-9 levels in a patient with choledocholithiasis","volume":"40","author":"Ca\u00f1ete-Ruiz A","year":"2017","unstructured":"Ca\u00f1ete-Ruiz A, Nu\u00f1ez-Gomez L, Moreira Vicente V, Cu\u00f1o Rold\u00e1n JL, Zaera de la Fuente C, Sierra Morales M. Significantly elevated CA 19-9 levels in a patient with choledocholithiasis. Gastroenterol Hepatol. 2017, 40:300-2. 10.1016\/j.gastrohep.2016.02.008","journal-title":"Gastroenterol Hepatol"},{"key":"ref14","article-title":"Elevated CA19-9 levels; not always cancer [Article in Dutch]","volume":"164","author":"Haring MPD","year":"2021","unstructured":"Haring MPD, de Cort BA, Nieuwenhuijs VB. Elevated CA19-9 levels; not always cancer [Article in Dutch]. Ned Tijdschr Geneeskd. 2021, 164:D4048.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.12739","article-title":"Unusual cause of a polypoid lesion in the extrahepatic bile duct","volume":"6","author":"Tan YB","year":"2022","unstructured":"Tan YB, Wang LM, Kwek ABE. Unusual cause of a polypoid lesion in the extrahepatic bile duct. JGH Open. 2022, 6:282-4. 10.1002\/jgh3.12739","journal-title":"JGH Open"},{"key":"ref16","article-title":"A case of hydronephrosis caused by renal stones with elevated serum levels of CA-19-9 and CA-125 [Article in Japanese]","volume":"40","author":"Ito S","year":"1994","unstructured":"Ito S, Nishikawa K, Goto T, Tsujita M, Takegaki Y, Kishimoto T. A case of hydronephrosis caused by renal stones with elevated serum levels of CA-19-9 and CA-125 [Article in Japanese]. Hinyokika Kiyo. 1994, 40:885-8.","journal-title":"Hinyokika Kiyo"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.38.887","article-title":"Giant hydronephrosis due to a ureteral stone, and elevated serum levels of CA 19-9","volume":"38","author":"Shudo R","year":"1999","unstructured":"Shudo R, Saito T, Takahashi K, Horita K, Waku K, Honma I, Sato T. Giant hydronephrosis due to a ureteral stone, and elevated serum levels of CA 19-9. Intern Med. 1999, 38:887-91. 10.2169\/internalmedicine.38.887","journal-title":"Intern Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.12659\/ajcr.897900","article-title":"Benign hydronephrosis and elevated of serum levels of carbohydrate antigen CA 19-9: a case report","volume":"17","author":"Filipovic B","year":"2016","unstructured":"Filipovic B, Milini\u0107 N, Gacic J, Markovic O, Djokovic A, Filipovic B. Benign hydronephrosis and elevated of serum levels of carbohydrate antigen CA 19-9: a case report. Am J Case Rep. 2016, 17:395-7. 10.12659\/ajcr.897900","journal-title":"Am J Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/128569-a-case-of-choledocholithiasis-and-obstructive-jaundice-with-a-very-high-serum-carbohydrate-antigen-19-9-ca-19-9-level-a-case-report-and-review-of-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:52:58Z","timestamp":1707508378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/128569-a-case-of-choledocholithiasis-and-obstructive-jaundice-with-a-very-high-serum-carbohydrate-antigen-19-9-ca-19-9-level-a-case-report-and-review-of-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.32447","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,12]]}}}